Key | % Net Assets |
---|---|
BT | 6.8% |
BP | 5.7% |
GlaxoSmithKline | 5.7% |
Rentokil Initial | 4.9% |
Other | 76.9% |
Name | % Net Assets |
---|---|
BT | 6.8% |
BP | 5.7% |
GlaxoSmithKline | 5.7% |
Rentokil Initial | 4.9% |
BAE Systems | 4.9% |
Imperial Tobacco | 4.6% |
BG | 4.4% |
AstraZeneca | 4.2% |
Legal & General | 3.8% |
Vodafone | 3.2% |
No asset data available.
Date | 08-May-2024 |
---|---|
NAV | 533.59p |
Currency | GBP |
Change | 3.73p |
% | 0.70% |
YTD change | 42.42p |
YTD % | 8.64% |
Fund Inception | 20/04/1988 |
---|---|
Fund Manager | Martin Walker |
TER | 1.73 (31-Dec-2013) |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | £100 |
Savings | £20 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.72% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.11 |
You are here: research